Intratracheal Dexmedetomidine Versus Lidocaine for Smooth Tracheal Extubation
Starting soon · Phase 4
Conditions studied: FESS Operation
In brief
compare the efficacy of intratracheal dexmedetomidine versus intratracheal lidocaine in achieving smooth tracheal extubation in patients undergoing Functional Endoscopic Sinus surgery and reconstructive nasal surgeries under general anesthesia.
Key facts
- Study ID
- NCT07504497
- Run by
- Younes Ahmed Younes
- People needed
- 120
- Starts
- 2026-04-15
- Expected to finish
- 2026-12-15
- Last updated by the study team
- 2026-03-31
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- - Age 18-60 years.
- Elective FESS under general anesthesia.
- ASA Physical Status I-II
You may not qualify if…
- Allergy to dexmedetomidine or lidocaine
- Anticipated difficult airway
- Chronic pulmonary diseases (asthma, COPD)
- Uncontrolled hypertension or ischemic heart disease
- Patient refusal
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.